Stem Stock News

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-driven clean energy software and services, today announced that Brian Musfeldt has been appointed Chief Financial Officer (CFO), effective July 17, 2025. Musfeldt succeeds Doran Hole, who is stepping down as CFO and EVP, effective July 17, 2025, to pursue other interests. Musfeldt returns to Stem ...

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM) (the “Company”), a global leader in AI-enabled clean energy software and services, today announced that it completed a privately negotiated exchange (the “Exchange Agreement”) with certain holders of the Company's outstanding 0.500% convertible senior notes due 2028 and 4.250% convertible senior notes due 2030 (the “Existing Notes”).The transact...

HOUSTON--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that Norbut Solar Farms (NSF), a leading community solar developer in the New York ISO (NYISO) power market, will standardize on Stem's PowerTrack™ software to scale and manage its growing portfolio of solar projects. The collaboration will enable NSF to accelerate its ...

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM) (the “Company” or “Stem”) today announced that it will implement a 1-for-20 reverse stock split of the issued and outstanding shares of the Company's common stock, effective at 12:01 a.m. Eastern Time on June 23, 2025 (the “Effective Time”), in order to regain compliance with the minimum average closing price requirement under the rules of the N...

SAN FRANCISCO--(BUSINESS WIRE)--Stem (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced its role in the engineering advisory and design support of Green River Energy Center. Stem's services for the project include energy storage metering configuration, review of power flow scenarios, and auxiliary load assumptions. Developed and indirectly owned by r...

Study conducted at The Massachusetts General Hospital's Vaccine and Immunotherapy Center demonstrated highly significant improvements in Overall Survival and other key endpoints VTX-0P4, in combination with a CPI, had a statistically significant improvement in survival versus a CPI alone Key targets include Urothelial, Prostate, and Renal Cancers  VTX-0P4 produced a safety profile similar to th...

Stem, Inc. (NYSE:STEM ) Q1 2025 Earnings Conference Call April 29, 2025 5:00 PM ET Company Participants Ted Durbin - Head, IR Arun Narayanan - CEO Doran Hole - CFO and EVP Conference Call Participants Justin Clare - ROTH Capital Partners Thomas Boyes - TD Cowen Dylan Nassano - Wolfe Research Operator Greetings, and welcome to the Stem, Inc. First Quarter 2025 Results Conference Call. At this ti...

SAN FRANCISCO--(BUSINESS WIRE)--Stem, Inc. announces financial results for the three months ended March 31, 2025.